Phase II Study of Gemcitabine, Oxaliplatin in Combination With Bevacizumab (Avastin) in Unresectable or Metastatic Biliary Tract and Gallbladder Cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Bevacizumab (Primary) ; Gemcitabine; Oxaliplatin
- Indications Biliary cancer; Gallbladder cancer
- Focus Therapeutic Use
- 11 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Oct 2006 New trial record.